Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Jazz Pharmaceuticals plc | Director | Ordinary Shares | 14.9K | $1.77M | $119.13 | Aug 14, 2023 | Direct |
LANDEC CORP \CA\ | Director | Common Stock | 54.1K | $563K | $10.42 | Jun 4, 2022 | Direct |
Altimmune, Inc. | Director | Stock Options (option to buy) | 34.9K | Sep 26, 2024 | Direct | ||
Rubius Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 25K | May 12, 2022 | Direct | ||
Axcella Health Inc. | Director | Stock Option (Right to Buy) | 20K | May 19, 2022 | Direct | ||
LANDEC CORP \CA\ | Director | Restricted Stock Unit | 0 | $7.00 | Jun 4, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ALT | Altimmune, Inc. | Sep 26, 2024 | 1 | $0 | 4 | Sep 30, 2024 | Director |
ALT | Altimmune, Inc. | Sep 28, 2023 | 1 | $0 | 4 | Sep 29, 2023 | Director |
JAZZ | Jazz Pharmaceuticals plc | Aug 11, 2023 | 2 | -$171K | 4 | Aug 15, 2023 | Director |
ALT | Altimmune, Inc. | Mar 23, 2023 | 1 | $0 | 4 | Mar 27, 2023 | Director |
ALT | Altimmune, Inc. | Mar 23, 2023 | 0 | $0 | 3 | Mar 27, 2023 | Director |
JAZZ | Jazz Pharmaceuticals plc | Aug 5, 2022 | 2 | -$166K | 4 | Aug 9, 2022 | Director |
LFCR | LANDEC CORP \CA\ | Jun 4, 2022 | 2 | $0 | 4 | Jun 7, 2022 | Director |
LFCR | LANDEC CORP \CA\ | May 31, 2022 | 1 | $0 | 4 | Jun 2, 2022 | Director |
AXLA | Axcella Health Inc. | May 19, 2022 | 1 | $0 | 4 | May 23, 2022 | Director |
RUBY | Rubius Therapeutics, Inc. | May 12, 2022 | 1 | $0 | 4 | May 13, 2022 | Director |
JAZZ | Jazz Pharmaceuticals plc | Aug 6, 2021 | 1 | -$193K | 4 | Aug 10, 2021 | Director |
JAZZ | Jazz Pharmaceuticals plc | Jul 29, 2021 | 1 | $0 | 4 | Aug 2, 2021 | Director |
LFCR | LANDEC CORP \CA\ | Jun 4, 2021 | 1 | $0 | 4 | Jun 8, 2021 | Director |
LFCR | LANDEC CORP \CA\ | Jun 1, 2021 | 2 | $0 | 4 | Jun 3, 2021 | Director |
AXLA | Axcella Health Inc. | May 20, 2021 | 1 | $0 | 4 | May 24, 2021 | Director |
RUBY | Rubius Therapeutics, Inc. | May 12, 2021 | 1 | $0 | 4 | May 13, 2021 | Director |